Shire has announced that James Bowling, the Dublin-based drug developer’s interim chief financial officer, is stepping down only days after the board of AbbVie walked away from a $54 billion planned takeover of the company.
from WSJ.com: US Business http://ift.tt/1vTGnLX
via IFTTT
from WSJ.com: US Business http://ift.tt/1vTGnLX
via IFTTT
No comments:
Post a Comment